Bellerophon Therapeutics (BLPH) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts BLPH Hot Sheet
Join SI Premium – FREE
Bellerophon Therapeutics (NASDAQ: BLPH) reported Q2 EPS of ($0.39), $0.12 better than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
